Invex Non Current Liabilities Total vs Net Receivables Analysis

IXC Stock   0.07  0  4.17%   
Invex Therapeutics financial indicator trend analysis is infinitely more than just investigating Invex Therapeutics recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Invex Therapeutics is a good investment. Please check the relationship between Invex Therapeutics Non Current Liabilities Total and its Net Receivables accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Non Current Liabilities Total vs Net Receivables

Non Current Liabilities Total vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Invex Therapeutics Non Current Liabilities Total account and Net Receivables. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Invex Therapeutics' Non Current Liabilities Total and Net Receivables is -0.06. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Invex Therapeutics, assuming nothing else is changed. The correlation between historical values of Invex Therapeutics' Non Current Liabilities Total and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Invex Therapeutics are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Non Current Liabilities Total i.e., Invex Therapeutics' Non Current Liabilities Total and Net Receivables go up and down completely randomly.

Correlation Coefficient

-0.06
Relationship DirectionNegative 
Relationship StrengthInsignificant

Non Current Liabilities Total

Net Receivables

Most indicators from Invex Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Invex Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invex Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Issuance Of Capital Stock is likely to gain to about 10 M in 2024, whereas Selling General Administrative is likely to drop slightly above 1.1 M in 2024.
 2022 2023 2024 (projected)
Gross Profit459.1K1.2M1.3M
Total Revenue459.1K1.2M1.3M

Invex Therapeutics fundamental ratios Correlations

0.51.00.48-1.0-0.04-0.331.0-0.460.461.00.150.49-0.210.15-0.530.51.00.66-0.280.460.410.640.850.64
0.50.46-0.03-0.490.190.180.49-0.540.530.490.44-0.02-0.510.440.261.00.50.130.260.530.140.410.280.41
1.00.460.5-1.0-0.05-0.351.0-0.440.441.00.130.5-0.190.13-0.550.461.00.67-0.30.440.420.630.860.63
0.48-0.030.5-0.5-0.85-0.790.490.52-0.430.490.350.99-0.310.35-0.89-0.030.490.92-0.92-0.43-0.04-0.340.44-0.34
-1.0-0.49-1.0-0.50.050.35-1.00.45-0.44-1.0-0.15-0.50.2-0.150.54-0.49-1.0-0.670.29-0.44-0.41-0.63-0.85-0.63
-0.040.19-0.05-0.850.050.55-0.04-0.720.7-0.04-0.59-0.870.51-0.590.740.19-0.04-0.750.920.70.210.7-0.190.7
-0.330.18-0.35-0.790.350.55-0.34-0.550.55-0.340.16-0.76-0.230.160.650.18-0.33-0.670.580.55-0.090.34-0.080.34
1.00.491.00.49-1.0-0.04-0.34-0.450.451.00.140.49-0.20.14-0.530.491.00.66-0.290.450.410.630.850.63
-0.46-0.54-0.440.520.45-0.72-0.55-0.45-0.8-0.450.030.490.050.03-0.35-0.54-0.450.21-0.58-0.8-0.36-0.9-0.45-0.9
0.460.530.44-0.43-0.440.70.550.45-0.80.45-0.11-0.45-0.04-0.110.350.530.45-0.310.521.00.350.890.360.89
1.00.491.00.49-1.0-0.04-0.341.0-0.450.450.140.49-0.20.14-0.530.491.00.66-0.290.450.410.630.850.63
0.150.440.130.35-0.15-0.590.160.140.03-0.110.140.44-0.981.0-0.280.440.150.49-0.46-0.11-0.06-0.240.4-0.24
0.49-0.020.50.99-0.5-0.87-0.760.490.49-0.450.490.44-0.390.44-0.91-0.020.490.95-0.93-0.450.01-0.340.49-0.34
-0.21-0.51-0.19-0.310.20.51-0.23-0.20.05-0.04-0.2-0.98-0.39-0.980.24-0.51-0.21-0.440.41-0.040.020.13-0.440.13
0.150.440.130.35-0.15-0.590.160.140.03-0.110.141.00.44-0.98-0.280.440.150.49-0.46-0.11-0.06-0.240.4-0.24
-0.530.26-0.55-0.890.540.740.65-0.53-0.350.35-0.53-0.28-0.910.24-0.280.26-0.53-0.90.930.35-0.130.15-0.650.15
0.51.00.46-0.03-0.490.190.180.49-0.540.530.490.44-0.02-0.510.440.260.50.130.260.530.140.410.280.41
1.00.51.00.49-1.0-0.04-0.331.0-0.450.451.00.150.49-0.210.15-0.530.50.67-0.290.450.410.630.850.63
0.660.130.670.92-0.67-0.75-0.670.660.21-0.310.660.490.95-0.440.49-0.90.130.67-0.85-0.310.11-0.120.69-0.12
-0.280.26-0.3-0.920.290.920.58-0.29-0.580.52-0.29-0.46-0.930.41-0.460.930.26-0.29-0.850.520.120.44-0.450.44
0.460.530.44-0.43-0.440.70.550.45-0.81.00.45-0.11-0.45-0.04-0.110.350.530.45-0.310.520.350.890.360.89
0.410.140.42-0.04-0.410.21-0.090.41-0.360.350.41-0.060.010.02-0.06-0.130.140.410.110.120.350.460.380.46
0.640.410.63-0.34-0.630.70.340.63-0.90.890.63-0.24-0.340.13-0.240.150.410.63-0.120.440.890.460.551.0
0.850.280.860.44-0.85-0.19-0.080.85-0.450.360.850.40.49-0.440.4-0.650.280.850.69-0.450.360.380.550.55
0.640.410.63-0.34-0.630.70.340.63-0.90.890.63-0.24-0.340.13-0.240.150.410.63-0.120.440.890.461.00.55
Click cells to compare fundamentals

Invex Therapeutics Account Relationship Matchups

Invex Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets26.4M32.7M29.5M22.8M6.1M5.8M
Total Current Liabilities2.0M658.6K1.0M1.6M431.6K410.0K
Total Stockholder Equity24.4M32.1M28.5M21.2M5.7M5.4M
Net Debt(26.3M)(32.7M)(29.3M)(22.5M)(6.0M)(6.3M)
Retained Earnings(3.6M)(5.9M)(9.8M)(17.6M)(19.2M)(18.3M)
Accounts Payable30.4K11.3K138.8K1.1M5.6K5.3K
Cash26.3M32.7M29.3M22.5M6.0M5.7M
Cash And Short Term Investments26.3M32.7M29.3M22.5M6.0M5.7M
Net Receivables116.9K21.2K145.7K333.6K95.0K146.3K
Liabilities And Stockholders Equity26.4M32.7M29.5M22.8M6.1M5.8M
Inventory(116.9K)(21.2K)(145.7K)(333.6K)(95.0K)(99.7K)
Other Current Assets116.9K21.2K145.7K333.6K95.0K146.3K
Other Stockholder Equity977.2K(30.5M)(26.6M)(18.8M)(17.0M)(17.8M)
Total Liab2.0M658.6K1.0M1.6M431.6K410.0K
Total Current Assets26.4M32.7M29.5M22.8M6.1M5.8M
Accumulated Other Comprehensive Income977.2K1.5M1.9M2.4M2.5M1.5M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Invex Stock Analysis

When running Invex Therapeutics' price analysis, check to measure Invex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Invex Therapeutics is operating at the current time. Most of Invex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Invex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Invex Therapeutics' price. Additionally, you may evaluate how the addition of Invex Therapeutics to your portfolios can decrease your overall portfolio volatility.